The use of probiotics and synbiotics in the food industry or as food supplements for a balanced diet and improved gut homeostasis has been blooming for the past decade. As feedback from healthy consumers is rather enthusiastic, a lot of effort is currently directed in elucidating the mechanisms of interaction between beneficial microbes and barrier and immune function of the host. The use of probiotics or synbiotics for treating certain pathologies has also been examined, however, the outcome has not always been favourable. In most cases, the effect of the administered probiotic is evident when the bacteria are still alive at the time they reach the small and large intestine, suggesting that it is dependent on the metabolic activity of the bacteria. Indeed, in some occasions it has been shown that the culture supernatant of these bacteria mediates the immunomodulatory effect conferred to the host. Recent work on relevant probiotic strains has also led to the isolation and characterisation of certain probiotic-produced, soluble factors, here called postbiotics, which were sufficient to elicit the desired response. Here, we summarise these recent findings and propose the use of purified and well characterised postbiotic components as a safer alternative for clinical applications, especially in chronic inflammatory conditions like inflammatory bowel disease, where probiotics have not yet given encouraging results as far as induction of remission is concerned.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
Bernardo, D., Sanchez, B., Al-Hassi, H.O., Mann, E.R., Urdaci, M.C., Knight, S.C. and Margolles, A., 2012. Microbiota/host crosstalk biomarkers: regulatory response of human intestinal dendritic cells exposed to Lactobacillus extracellular encrypted peptide. PloS ONE 7: e36262.
'Microbiota/host crosstalk biomarkers: regulatory response of human intestinal dendritic cells exposed to Lactobacillus extracellular encrypted peptide ' () 7 PloS ONE : e36262 .
Besselink, M.G., Van Santvoort, H.C., Buskens, E., Boermeester, M.A., Van Goor, H., Timmerman, H.M., Nieuwenhuijs, V.B., Bollen, T.L., Van Ramshorst, B., Witteman, B.J., Rosman, C., Ploeg, R.J., Brink, M.A., Schaapherder, A.F., De Jong, C.H., Wahab, P.J., Van Laarhoven, C.J., Van der Harst, E., Van Eijck, C.H., Cuesta, M.A., Akkermans, L.M. and Gooszen, H.G., 2008. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. The Lancet 371: 651-659.
'Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial ' () 371 The Lancet : 651 -659 .
Boge, T., Remigy, M., Vaudaine, S., Tanguy, J., Bourdet-Sicard, R. and Van der Werf, S., 2009. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27: 5677-5684.
'A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials ' () 27 Vaccine : 5677 -5684 .
Canonici, A., Siret, C., Pellegrino, E., Pontier-Bres, R., Pouyet, L., Montero, M.P., Colin, C., Czerucka, D., Rigot, V. and Andre, F., 2011. Saccharomyces boulardii improves intestinal cell restitution through activation of the alpha2beta1 integrin collagen receptor. PloS ONE 6: e18427.
'Saccharomyces boulardii improves intestinal cell restitution through activation of the alpha2beta1 integrin collagen receptor ' () 6 PloS ONE : e18427 .
Chamaillard, M. and Dessein, R., 2011. Defensins couple dysbiosis to primary immunodeficiency in Crohn's disease. World Journal of Gastroenterology 17: 567-571.
'Defensins couple dysbiosis to primary immunodeficiency in Crohn's disease ' () 17 World Journal of Gastroenterology : 567 -571 .
Chow, J., Tang, H. and Mazmanian, S.K., 2011. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Current Opinion in Immunology 23: 473-480.
'Pathobionts of the gastrointestinal microbiota and inflammatory disease ' () 23 Current Opinion in Immunology : 473 -480 .
Corridoni, D., Pastorelli, L., Mattioli, B., Locovei, S., Ishikawa, D., Arseneau, K.O., Chieppa, M., Cominelli, F. and Pizarro, T.T., 2012. Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism. PloS ONE 7: e42067.
'Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism ' () 7 PloS ONE : e42067 .
Dobson, A., Cotter, P.D., Ross, R.P. and Hill, C., 2012. Bacteriocin production: a probiotic trait? Applied and Environmental Microbiology 78: 1-6.
'Bacteriocin production: a probiotic trait? ' () 78 Applied and Environmental Microbiology : 1 -6 .
Drago, L., Iemoli, E., Rodighiero, V., Nicola, L., De Vecchi, E. and Piconi, S., 2011. Effects of Lactobacillus salivarius LS01 (DSM 22775) treatment on adult atopic dermatitis: a randomized placebo-controlled study. International Journal of Immunopathology and Pharmacology 24: 1037-1048.
'Effects of Lactobacillus salivarius LS01 (DSM 22775) treatment on adult atopic dermatitis: a randomized placebo-controlled study ' () 24 International Journal of Immunopathology and Pharmacology : 1037 -1048 .
Dykstra, N.S., Hyde, L., Adawi, D., Kulik, D., Ahrne, S., Molin, G., Jeppsson, B., Mackenzie, A. and Mack, D.R., 2011. Pulse probiotic administration induces repeated small intestinal Muc3 expression in rats. Pediatric Research 69: 206-211.
'Pulse probiotic administration induces repeated small intestinal Muc3 expression in rats ' () 69 Pediatric Research : 206 -211 .
Fanning, S., Hall, L.J., Cronin, M., Zomer, A., MacSharry, J., Goulding, D., Motherway, M.O., Shanahan, F., Nally, K., Dougan, G. and Van Sinderen, D., 2012. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proceedings of the National Academy of Sciences of the USA 109: 2108-2113.
'Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection ' () 109 Proceedings of the National Academy of Sciences of the USA : 2108 -2113 .
Jeppsson, B., Mangell, P. and Thorlacius, H., 2011. Use of probiotics as prophylaxis for postoperative infections. Nutrients 3: 604-612.
'Use of probiotics as prophylaxis for postoperative infections ' () 3 Nutrients : 604 -612 .
Jimenez, E., Fernandez, L., Maldonado, A., Martin, R., Olivares, M., Xaus, J. and Rodriguez, J.M., 2008. Oral administration of Lactobacillus strains isolated from breast milk as an alternative for the treatment of infectious mastitis during lactation. Applied and Environmental Microbiology 74: 4650-4655.
'Oral administration of Lactobacillus strains isolated from breast milk as an alternative for the treatment of infectious mastitis during lactation ' () 74 Applied and Environmental Microbiology : 4650 -4655 .
Kaci, G., Lakhdari, O., Dore, J., Ehrlich, S.D., Renault, P., Blottiere, H.M. and Delorme, C., 2011. Inhibition of the NF-kappaB pathway in human intestinal epithelial cells by commensal Streptococcus salivarius. Applied and Environmental Microbiology 77: 4681-4684.
'Inhibition of the NF-kappaB pathway in human intestinal epithelial cells by commensal Streptococcus salivarius ' () 77 Applied and Environmental Microbiology : 4681 -4684 .
Konstantinov, S.R., Smidt, H., De Vos, W.M., Bruijns, S.C., Singh, S.K., Valence, F., Molle, D., Lortal, S., Altermann, E., Klaenhammer, T.R. and Van Kooyk, Y., 2008. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proceedings of the National Academy of Sciences of the USA 105: 19474-19479.
'S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions ' () 105 Proceedings of the National Academy of Sciences of the USA : 19474 -19479 .
Kwon, H.K., Lee, C.G., So, J.S., Chae, C.S., Hwang, J.S., Sahoo, A., Nam, J.H., Rhee, J.H., Hwang, K.C. and Im, S.H., 2010. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proceedings of the National Academy of Sciences of the USA 107: 2159-2164.
'Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders ' () 107 Proceedings of the National Academy of Sciences of the USA : 2159 -2164 .
Lavasani, S., Dzhambazov, B., Nouri, M., Fak, F., Buske, S., Molin, G., Thorlacius, H., Alenfall, J., Jeppsson, B. and Westrom, B., 2010. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PloS ONE 5: e9009.
'A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells ' () 5 PloS ONE : e9009 .
Lee, Y.K., Menezes, J.S., Umesaki, Y. and Mazmanian, S.K., 2011. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the USA 108 Suppl. 1: 4615-4622.
'Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis ' () 108 Proceedings of the National Academy of Sciences of the USA : 4615 -4622 .
Li, J., Wang, W., Xu, S.X., Magarvey, N.A. and McCormick, J.K., 2011. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proceedings of the National Academy of Sciences of the USA 108: 3360-3365.
'Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci ' () 108 Proceedings of the National Academy of Sciences of the USA : 3360 -3365 .
Ligaarden, S.C., Axelsson, L., Naterstad, K., Lydersen, S. and Farup, P.G., 2010. A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial. BMC Gastroenterology 10: 16.
'A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial ' () 10 BMC Gastroenterology : 16 .
Littman, D.R. and Pamer, E.G., 2011. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 10: 311-323.
'Role of the commensal microbiota in normal and pathogenic host immune responses ' () 10 Cell Host Microbe : 311 -323 .
Macho Fernandez, E., Valenti, V., Rockel, C., Hermann, C., Pot, B., Boneca, I.G. and Grangette, C., 2011. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 60: 1050-1059.
'Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide ' () 60 Gut : 1050 -1059 .
Mack, D.R., Michail, S., Wei, S., McDougall, L. and Hollingsworth, M.A., 1999. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. American Journal of Physiology 276: G941-950.
'Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression ' () 276 American Journal of Physiology : G941 -950 .
Mazmanian, S.K., Round, J.L. and Kasper, D.L., 2008. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453: 620-625.
'A microbial symbiosis factor prevents intestinal inflammatory disease ' () 453 Nature : 620 -625 .
Meijer, B.J. and Dieleman, L.A., 2011. Probiotics in the treatment of human inflammatory bowel diseases: update 2011. Journal of Clinical Gastroenterology 45 Suppl.: S139-144.
'Probiotics in the treatment of human inflammatory bowel diseases: update 2011 ' () 45 Journal of Clinical Gastroenterology : S139 -144 .
Menard, S., Candalh, C., Bambou, J.C., Terpend, K., Cerf-Bensussan, N. and Heyman, M., 2004. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 53: 821-828.
'Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport ' () 53 Gut : 821 -828 .
Menard, S., Laharie, D., Asensio, C., Vidal-Martinez, T., Candalh, C., Rullier, A., Zerbib, F., Megraud, F., Matysiak-Budnik, T. and Heyman, M., 2005. Bifidobacterium breve and Streptococcus thermophilus secretion products enhance T helper 1 immune response and intestinal barrier in mice. Experimental Biology and Medicine 230: 749-756.
'Bifidobacterium breve and Streptococcus thermophilus secretion products enhance T helper 1 immune response and intestinal barrier in mice ' () 230 Experimental Biology and Medicine : 749 -756 .
Mileti, E., Matteoli, G., Iliev, I.D. and Rescigno, M., 2009. Comparison of the immunomodulatory properties of three probiotic strains of lactobacilli using complex culture systems: prediction for in vivo efficacy. PloS ONE 4: e7056.
'Comparison of the immunomodulatory properties of three probiotic strains of lactobacilli using complex culture systems: prediction for in vivo efficacy ' () 4 PloS ONE : e7056 .
Mondel, M., Schroeder, B.O., Zimmermann, K., Huber, H., Nuding, S., Beisner, J., Fellermann, K., Stange, E.F. and Wehkamp, J., 2009. Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunology 2: 166-172.
'Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans ' () 2 Mucosal Immunology : 166 -172 .
Morrow, L.E., Gogineni, V. and Malesker, M.A., 2012. Probiotics in the intensive care unit. Nutrition in Clinical Practice 27: 235-241.
'Probiotics in the intensive care unit ' () 27 Nutrition in Clinical Practice : 235 -241 .
Na, X. and Kelly, C., 2011. Probiotics in Clostridium difficile infection. Journal of Clinical Gastroenterology 45 Suppl.: S154-S158.
'Probiotics in Clostridium difficile infection ' () 45 Journal of Clinical Gastroenterology : S154 -S158 .
Nishikawa, J., Kudo, T., Sakata, S., Benno, Y. and Sugiyama, T., 2009. Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis. Scandinavian Journal of Gastroenterology 44: 180-186.
'Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis ' () 44 Scandinavian Journal of Gastroenterology : 180 -186 .
O'Hara, A.M., O'Regan, P., Fanning, A., O'Mahony, C., Macsharry, J., Lyons, A., Bienenstock, J., O'Mahony, L. and Shanahan, F., 2006. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 118: 202-215.
'Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius ' () 118 Immunology : 202 -215 .
Pagnini, C., Saeed, R., Bamias, G., Arseneau, K.O., Pizarro, T.T. and Cominelli, F., 2010. Probiotics promote gut health through stimulation of epithelial innate immunity. Proceedings of the National Academy of Sciences of the USA 107: 454-459.
'Probiotics promote gut health through stimulation of epithelial innate immunity ' () 107 Proceedings of the National Academy of Sciences of the USA : 454 -459 .
Png, C.W., Linden, S.K., Gilshenan, K.S., Zoetendal, E.G., McSweeney, C.S., Sly, L.I., McGuckin, M.A. and Florin, T.H., 2010. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. The American Journal of Gastroenterology 105: 2420-2428.
'Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria ' () 105 The American Journal of Gastroenterology : 2420 -2428 .
Rayes, N., Seehofer, D., Theruvath, T., Schiller, R.A., Langrehr, J.M., Jonas, S., Bengmark, S. and Neuhaus, P., 2005. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized, double-blind trial. American Journal of Transplantation 5: 125-130.
'Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized, double-blind trial ' () 5 American Journal of Transplantation : 125 -130 .
Rescigno, M., 2011. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends in Immunology 32: 256-264.
'The intestinal epithelial barrier in the control of homeostasis and immunity ' () 32 Trends in Immunology : 256 -264 .
Rimoldi, M., Chieppa, M., Salucci, V., Avogadri, F., Sonzogni, A., Sampietro, G.M., Nespoli, A., Viale, G., Allavena, P. and Rescigno, M., 2005. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nature Immunology 6: 507-514.
'Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells ' () 6 Nature Immunology : 507 -514 .
Ritchie, M.L. and Romanuk, T.N., 2012. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PloS ONE 7: e34938.
'A meta-analysis of probiotic efficacy for gastrointestinal diseases ' () 7 PloS ONE : e34938 .
Schlee, M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T.A., Stange, E.F. and Fellermann, K., 2007. Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infection and Immunity 75: 2399-2407.
'Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin ' () 75 Infection and Immunity : 2399 -2407 .
Segawa, S., Fujiya, M., Konishi, H., Ueno, N., Kobayashi, N., Shigyo, T. and Kohgo, Y., 2011. Probiotic-derived polyphosphate enhances the epithelial barrier function and maintains intestinal homeostasis through integrin-p38 MAPK pathway. PloS ONE 6: e23278.
'Probiotic-derived polyphosphate enhances the epithelial barrier function and maintains intestinal homeostasis through integrin-p38 MAPK pathway ' () 6 PloS ONE : e23278 .
Sepehri, S., Kotlowski, R., Bernstein, C.N. and Krause, D.O., 2007. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflammatory Bowel Diseases 13: 675-683.
'Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease ' () 13 Inflammatory Bowel Diseases : 675 -683 .
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L.G., Gratadoux, J.J., Blugeon, S., Bridonneau, C., Furet, J.P., Corthier, G., Grangette, C., Vasquez, N., Pochart, P., Trugnan, G., Thomas, G., Blottiere, H.M., Dore, J., Marteau, P., Seksik, P. and Langella, P., 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of Sciences of the USA 105: 16731-16736.
'Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients ' () 105 Proceedings of the National Academy of Sciences of the USA : 16731 -16736 .
The Human Microbiome Project Consortium, 2012. Structure, function and diversity of the healthy human microbiome. Nature 486: 207-214.
Toivanen, P., 2003. Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis. Annals of the Rheumatic Diseases 62: 807-811.
'Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis ' () 62 Annals of the Rheumatic Diseases : 807 -811 .
Tsilingiri, K., Barbosa, T., Penna, G., Caprioli, F., Sonzogni, A., Viale, G. and Rescigno, M., 2012. Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Gut 61: 1007-1015..
'Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model ' () 61 Gut : 1007 -1015 .
Van Hemert, S., Meijerink, M., Molenaar, D., Bron, P.A., De Vos, P., Kleerebezem, M., Wells, J.M. and Marco, M.L., 2010. Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells. BMC Microbiology 10: 293.
'Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells ' () 10 BMC Microbiology : 293 .
Von Schillde, M.A., Hormannsperger, G., Weiher, M., Alpert, C.A., Hahne, H., Bauerl, C., Van Huynegem, K., Steidler, L., Hrncir, T., Perez-Martinez, G., Kuster, B. and Haller, D., 2012. Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host Microbe 11: 387-396.
'Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines ' () 11 Cell Host Microbe : 387 -396 .
Wen, L., Ley, R.E., Volchkov, P.Y., Stranges, P.B., Avanesyan, L., Stonebraker, A.C., Hu, C., Wong, F.S., Szot, G.L., Bluestone, J.A., Gordon, J.I. and Chervonsky, A.V., 2008. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455: 1109-1113.
'Innate immunity and intestinal microbiota in the development of type 1 diabetes ' () 455 Nature : 1109 -1113 .
Yan, F., Cao, H., Cover, T.L., Washington, M.K., Shi, Y., Liu, L., Chaturvedi, R., Peek Jr., R.M., Wilson, K.T. and Polk, D.B., 2011. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. The Journal of Clinical Investigation 121: 2242-2253.
'Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism ' () 121 The Journal of Clinical Investigation : 2242 -2253 .
Zhang, J.W., Du, P., Gao, J., Yang, B.R., Fang, W.J. and Ying, C.M., 2012. Preoperative probiotics decrease postoperative infectious complications of colorectal cancer. The American Journal of the Medical Sciences 343: 199-205.
'Preoperative probiotics decrease postoperative infectious complications of colorectal cancer ' () 343 The American Journal of the Medical Sciences : 199 -205 .
All Time | Past 365 days | Past 30 Days | |
---|---|---|---|
Abstract Views | 2094 | 1700 | 232 |
Full Text Views | 67 | 59 | 39 |
PDF Views & Downloads | 95 | 76 | 21 |
The use of probiotics and synbiotics in the food industry or as food supplements for a balanced diet and improved gut homeostasis has been blooming for the past decade. As feedback from healthy consumers is rather enthusiastic, a lot of effort is currently directed in elucidating the mechanisms of interaction between beneficial microbes and barrier and immune function of the host. The use of probiotics or synbiotics for treating certain pathologies has also been examined, however, the outcome has not always been favourable. In most cases, the effect of the administered probiotic is evident when the bacteria are still alive at the time they reach the small and large intestine, suggesting that it is dependent on the metabolic activity of the bacteria. Indeed, in some occasions it has been shown that the culture supernatant of these bacteria mediates the immunomodulatory effect conferred to the host. Recent work on relevant probiotic strains has also led to the isolation and characterisation of certain probiotic-produced, soluble factors, here called postbiotics, which were sufficient to elicit the desired response. Here, we summarise these recent findings and propose the use of purified and well characterised postbiotic components as a safer alternative for clinical applications, especially in chronic inflammatory conditions like inflammatory bowel disease, where probiotics have not yet given encouraging results as far as induction of remission is concerned.
All Time | Past 365 days | Past 30 Days | |
---|---|---|---|
Abstract Views | 2094 | 1700 | 232 |
Full Text Views | 67 | 59 | 39 |
PDF Views & Downloads | 95 | 76 | 21 |